Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice CT

Phase 2CompletedNCT00311038

Ono Pharmaceutical Co., Ltd.90 enrolled

Overview

The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in patients scheduled for multi-slice CT.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Coronary Artery Disease

Interventions

ONO-1101DRUG

Eligibility

Sex: ALLMin age: 20 YearsMax age: 74 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. 20-74 years old 2. Heart rate less than 90 beats/min more than 70 beats/min at entering the CT room Exclusion Criteria: 1. Previous allergic reactions to contrast agent 2. Renal failure 3. Asthma 4. Other exclusion criteria as specified in the protocol

Locations (3)

Hokuriku Region Facility

Hokuriku, Japan

Kanto Region Facility

Kanto, Japan

Kyusyu Region Facility

Kyusyu, Japan

Outcomes

Primary Outcomes

heart rate

image quality

safety

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.